超分辨超声成像观察淋巴结内淋巴窦预测乳腺癌前哨淋巴结转移的初步研究
该前瞻性研究纳入143例乳腺癌患者的154枚前哨淋巴结,经皮微泡注射后行超分辨超声(SRUS)成像观察淋巴窦,评估其预测前哨淋巴结转移的价值。SRUS预测转移的AUC为0.824,显著高于常规超声的0.661;两者联合AUC为0.844,显著高于常规超声,但与SRUS单独相比无显著差异。
要点
- SRUS可于十微米尺度成像前哨淋巴结的微淋巴循环。
- SRUS预测转移前哨淋巴结的AUC为0.824,优于常规超声的0.661。
- SRUS联合常规超声AUC为0.844,但与SRUS单独相比无显著差异。
核心结论
- SRUS成像淋巴窦有潜力预测乳腺癌患者的前哨淋巴结转移。
研究设计与样本
- 前瞻性研究,纳入143例乳腺癌患者的154枚前哨淋巴结,所有患者均行腋窝淋巴结常规超声及经皮微泡注射后淋巴窦SRUS成像,以定性(灌注缺损)和定量参数分析SRUS图像。
关键影像表现/征象
- SRUS定性分析聚焦于识别淋巴窦灌注缺损。
- SRUS定量分析参数包括淋巴窦密度、窦直径、窦距离和淋巴流速。
- 154枚前哨淋巴结中73枚为转移性、81枚为反应性。
诊断标准与关键数值
- SRUS预测转移性前哨淋巴结的AUC为0.824(95%CI:0.761-0.888)。
- 常规超声预测转移性前哨淋巴结的AUC为0.661(95%CI:0.596-0.726)。
- SRUS联合常规超声的AUC为0.844(95%CI:0.785-0.904)。
- SRUS的AUC显著高于常规超声(p < 0.001)。
- 联合方案AUC显著高于常规超声单独(p < 0.001),但与SRUS单独相比无显著差异(p = 0.2)。
临床应用与阅片要点
- SRUS是成像淋巴窦并表征乳腺癌转移性前哨淋巴结的可靠工具。
- SRUS有助于前哨淋巴结状态诊断及乳腺癌临床决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Accurate preoperative localization and characterization of sentinel lymph nodes (SLNs) is vital in breast cancer management. The application of super-resolution ultrasound (SRUS) imaging to visualize intranodal lymphatic sinuses for the prediction of SLN metastasis has yet to be investigated. The study aimed to assess the value of SRUS imaging of intranodal lymphatic sinuses in predicting SLN metastasis in breast cancer patients.
METHODS: A total of 154 SLNs from 143 patients with breast cancer were prospectively included. All patients underwent conventional US of axillary lymph nodes and SRUS imaging of lymph sinus by percutaneous microbubble injection. Qualitative and quantitative analysis were performed for SRUS imaging, with qualitative analysis focusing on identifying perfusion defects and quantitative analysis including parameters such as lymphatic sinus density, sinus diameter, sinus distance, and lymph flow velocity. The areas under the receiver operating characteristic curve (AUC), sensitivity, and specificity were calculated for conventional US, SRUS, and combined conventional US and SRUS.
RESULTS: Among the 154 SLNs, 73 were metastatic and 81 were reactive. In predicting metastatic SLNs, the AUC for SRUS (0.824; 95% CI: 0.761-0.888) was significantly higher than that for conventional US (0.661; 95% CI: 0.596-0.726) (p < 0.001). The combination of SRUS and conventional US achieved the highest AUC (0.844; 95% CI: 0.785-0.904), which was significantly higher than conventional US alone (p < 0.001), but not significantly different from SRUS alone (p = 0.2).
CONCLUSION: Imaging lymphatic sinuses by SRUS has the potential to predict metastatic SLNs in patients with breast cancer.
KEY POINTS: Question Super-resolution ultrasound (SRUS) used for visualizing intranodal lymphatic sinuses for the prediction of sentinel lymph nodes (SLNs) metastasis has yet to be investigated. Findings Microlymphatic circulation of SLNs were imaged by SRUS at ten microns scale. SRUS showed better performance for predicting metastatic SLNs than conventional ultrasound. Clinical relevance SRUS is a reliable tool to image lymphatic sinuses and characterize metastatic SLNs in patients with breast cancer. It helps diagnosis of lymph node status and clinical decision-making of breast cancer.
引用
- Xia S, Hua Q, Song Y, et al. Super-resolution ultrasound imaging of intranodal lymphatic sinuses for predicting sentinel lymph node metastasis in breast cancer: a preliminary study. Eur Radiol. 2025. PMID: 40186632. doi:10.1007/s00330-025-11520-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。